Editor's Note The Food and Drug Administration (FDA), on September 11, approved the Moderna and Pfizer/BioNTech updated COVID-19 boosters that target the Omicron subvariant XBB.1.5, the September 11 Reuters reports. The boosters, which were approved for those 12 years and older and authorized for emergency use for children ages 6…
Editor's Note The Non-Opioids Prevent Addiction in the Nation (NOPAIN) Act, which is set to take effect in 2025, will set up a separate Centers for Medicare and Medicaid Services (CMS) payment for certain nonopioid pain management techniques in outpatient and ambulatory surgery center (ASC) settings, the September 12 Becker’s…
Editor's Note The COVID-19 hospital admission rate in the US rose some 16% to more than 17,400 for the week ending August 26, and deaths increased by nearly 18% from the prior week, the September 7 New York Times reports. This marks the seventh consecutive week of increases. The Omicron…
Editor's Note The University of Miami School of Nursing and Health Studies, on September 5, announced that it had been awarded a $23.57 million grant from the National Institutes of Health (NIH). The grant will be used to fund a project to investigate how stress experienced by parents, and fueled…
Editor's Note The United States, in coordination with the United Kingdom, has imposed sanctions on 11 individuals linked to the Russia-based cybercrime group known as Trickbot, a US Department of the Treasury September 7 press release reports. These sanctions were issued by the US Department of the Treasury's Office of…
Editor's Notes Overall healthcare employment in the US was up in August to a seasonally adjusted 17,014,300 workers, the Bureau of Labor Statistics reported on September 1. That’s up 70,900 since July. Hospital employment also was up by 14,500 jobs. The overall unemployment rate rose in August to 3.8%, for…
Editor's Note The Food and Drug Administration (FDA), on August 31, identified the recall by Getinge/Maquet/Datasocpe of its Cardiosave Hybrid and Rescue Intra-aortic Balloon Pumps (IABPs) as Class I, the most serious. The FDA posted four recalls for four separate reasons: Because they may overheat when the device’s internal temperature…
Editor's Note The Food and Drug Administration (FDA), on August 30, identified the recall by Hamilton Medical of its HAMILTON-C1, C2, C3, and T1 ventilators as Class I, the most serious. The recall was initiated because of software issues that may cause the ventilators to stop without notice. There have…
Editor's Note An update of the 2014 “Strategies to Prevent Catheter-Associated Urinary Tract Infections [CAUTIs] in Acute-Care Hospitals” was published August 25 by the Society for Healthcare Epidemiology of America (SHEA). The update, which is a collaborative effort led by SHEA, the Infectious Diseases Society of America, the Association for…
Editor's Note The Department of Health and Human Services (HHS), on August 10, announced awards of more than $100 million to educate more nurses and grow the nursing workforce. The awards include: $8.7 million to help licensed practical nurses become RNs $34.8 million to increase the number of primary care…